Toxemia: Clinical Trials

3 trials for Toxemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Unknown 3

Follow Toxemia: new trials by email Literature Review of Toxemia trials Research Report on Toxemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Dexamethasone, Tocilizumab, Anakinra - Sepsis, Neuroinflammatory Response
Phase 4UnknownRadboud University Medical Center522024-10-242025-04-04
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
Vitamin D3 - Gestational Hypertension, Toxemia
Phase 4UnknownStony Brook University4122016-10-012017-10-05
Rifaximin Predicts the Complications of Decompensated Cirrhosis
rifaximin - Cirrhosis
Phase 4UnknownShanghai Changzheng Hospital2502013-10-012014-02-28

Narrower conditions

Endotoxemia (2)  ·  Eclampsia (1)  ·  Fibrosis (1)  ·  HELLP Syndrome (1)  ·  Hypertension, Pregnancy-Induced (1)  ·  Neuroinflammatory Diseases (1)  ·  Sepsis (1)

Broader conditions

Infections (3)  ·  Bacteremia (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Cardiovascular Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hypertension (1)  ·  Nervous System Diseases (1)  ·  Pregnancy Complications (1)  ·  Sepsis (1)  ·  Urogenital Diseases (1)  ·  Vascular Diseases (1)

Interventions

Cholecalciferol (1)  ·  Dexamethasone (1)  ·  Endotoxins (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Lipopolysaccharides (1)  ·  Rifaximin (1)  ·  Sodium Chloride (1)  ·  Vitamin D (1)  ·  tocilizumab (1)

Sponsors

Radboud University Medical Center (1)  ·  Shanghai Changzheng Hospital (1)  ·  Stony Brook University (1)

Countries

China (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Diana J Garretto, MD (1)  ·  Wei-Fen Xie, MD (1)

NIH funding

2023 (1)